Combining venetoclax and azacytidine with T-cell bispecific antibodies for treatment of acute myeloid leukemia: a preclinical assessment
2024 · Leukemia · 8 citations
https://doi.org/10.1038/s41375-023-02127-0
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
10
Papers
818
Citations
7
h-index
5
i10-index
Anne Schönle is an academic researcher from Roche (Switzerland). The author has contributed to research in topics: CAR-T cell therapy research & T-cell and B-cell Immunology & Immunotherapy and Immune Responses. The author has an h-index of 7, co-authored 9 publications.
Click to start Chat